Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
GlobeNewswire
*COPENHAGEN, Denmark, May 31, 2024* – Bavarian Nordic A/S (OMX: BAVA) today announced the submission of a supplemental Biologics..